{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:08:21Z","timestamp":1740143301973,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12024-019-00110-9","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T03:04:17Z","timestamp":1553915057000},"page":"458-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-3981","authenticated-orcid":false,"given":"John M.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"110_CR1","first-page":"161","volume-title":"WHO classification of tumors of the lung, pleura, thymus, and heart","author":"W Travis","year":"2015","unstructured":"Travis W, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumors of the lung, pleura, thymus, and heart. 4th ed. Lyon: International Agency for Research on Cancer; 2015. p. 161.","edition":"4"},{"key":"110_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos RL, Gibbs AR. 'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology. 2003;43:444\u201352.","journal-title":"Histopathology."},{"key":"110_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7243\/2052-7896-3-6","volume":"3","author":"SP Hammar","year":"2015","unstructured":"Hammar SP, Dodson RF. Pseudomesotheliomatous lung carcinoma: a pathological assessment of selected cases including the work history and presence of biomarkers suggesting it is a cancer caused by asbestos. Pathol Discov. 2015;3:6.","journal-title":"Pathol Discov"},{"key":"110_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1092-9134(98)80045-2","volume":"2","author":"MN Koss","year":"1998","unstructured":"Koss MN, Fleming M, Przygodzki RM, Sherrod A, Travis W, Hochholzer L. Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases. Ann Diagn Pathol. 1998;2:93\u2013102.","journal-title":"Ann Diagn Pathol"},{"key":"110_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1092-9134(99)80042-2","volume":"3","author":"IA Shah","year":"1999","unstructured":"Shah IA, Salvatore JR, Kummet T, Gani OS, Wheeler LA. Pseudomesotheliomatous carcinoma involving pleura and peritoneum: a clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol. 1999;3:148\u201359.","journal-title":"Ann Diagn Pathol"},{"key":"110_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.anndiagpath.2006.08.009","volume":"11","author":"J Pardo","year":"2007","unstructured":"Pardo J, Torres W, Martinez-Penuela A, Panizo A, de Alava E, Garcia JL. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. Ann Diagn Pathol. 2007;11:241\u201351.","journal-title":"Ann Diagn Pathol"},{"key":"110_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fonc.2018.00091","volume":"8","author":"M Rossini","year":"2018","unstructured":"Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, et al. New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Front Oncol. 2018;8:91.","journal-title":"Front Oncol"},{"key":"110_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.5858\/arpa.2013-0381-RA","volume":"139","author":"Q Arif","year":"2015","unstructured":"Arif Q, Husain AN. Malignant mesothelioma diagnosis. Arch Pathol Lab Med. 2015;139:978\u201380.","journal-title":"Arch Pathol Lab Med."},{"key":"110_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ordonez NG, Allen TC, Attanoos RL, Beasley MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142:89\u2013108.","journal-title":"Arch Pathol Lab Med"},{"key":"110_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.lungcan.2013.01.012","volume":"80","author":"S Bij van der","year":"2013","unstructured":"van der Bij S, Baas P, van de Vijver MJ, de Mol BA, Burgers JA. Legal claims for malignant mesothelioma: dealing with all cases. Lung Cancer. 2013;80:153\u20138.","journal-title":"Lung Cancer"},{"key":"110_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2559.2003.01685.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos RL, Thomas DH, Gibbs AR. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Histopathology. 2003;43:387\u201392.","journal-title":"Histopathology."},{"key":"110_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","volume":"6","author":"K Kadota","year":"2011","unstructured":"Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thoracic Oncol. 2011;6:896\u2013904.","journal-title":"J Thoracic Oncol"},{"key":"110_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","volume":"140","author":"A Churg","year":"2016","unstructured":"Churg A, Sheffield BS, Galateau-Sall\u2019e F. New markers for separating benign from malignant mesothelial proliferations: are we there yet? Arch Pathol Lab Med. 2016;140:318\u201321.","journal-title":"Arch Pathol Lab Med."},{"key":"110_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, Flores E, Napolitano A, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36:76\u201381.","journal-title":"Carcinogenesis."},{"key":"110_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.23907\/2013.050","volume":"3","author":"MA Graham","year":"2013","unstructured":"Graham MA, Roggli VL. Medicolegal aspects of asbestos I \u2014 malignant mesothelioma and lung cancer. Academic Forensic Pathol. 2013;3:386\u2013406.","journal-title":"Academic Forensic Pathol"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-019-00110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-019-00110-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-019-00110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T00:09:46Z","timestamp":1585440586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-019-00110-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s12024-019-00110-9","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"type":"print","value":"1547-769X"},{"type":"electronic","value":"1556-2891"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"11 March 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The article does not contain any studies with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The article does not include participants that require their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}